Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 5,404

Document Document Title
WO/2024/061348A1
The present invention provides a 1,3-cyclohexanedione compound shown in formula I, and a stereoisomer and an agrochemically acceptable salt thereof, wherein R1, R2, R3, and R4 are as defined in the description. Also disclosed are a prepa...  
WO/2024/056678A1
The present invention relates to compounds according to formula (I), which are prodrugs of the psychoactive compound phenethylamine or its derivatives. The prodrugs provided herein exhibit improved pharmacokinetic properties during uptak...  
WO/2024/043108A1
A photocurable composition containing a coloring agent, a radical polymerization initiator represented by formula (1) and a radically polymerizable compound; a method for producing a cured film using the photocurable composition; a film;...  
WO/2024/038436A1
The present invention relates to the preparation of cyantraniliprole, comprising the preparation of 8-methyl-2,4-dioxo-l,4-dihydro-2H-benzo[d][l,3]oxazine-6-car bonitrile key intermediate via 2-amino-5-((hydroxyimino)methyl)-3-methylbenz...  
WO/2024/031002A1
This disclosure includes pesticidal compounds, compositions, and related agricultural methods.  
WO/2023/244862A1
In one aspect, aryl carboximidamide compounds, comprising a carboximidamide molecular substructure, and modulating mammalian sirtuin enzymes (SIRT1-7) are described herein, and, in particular, to compounds for the modulation of SIRT3. No...  
WO/2023/236809A1
The present invention belongs to the technical field of anti-inflammatory drugs. Disclosed are a 2,6-dibenzylidene cyclohexanone oxime compound, a method for preparing same, and use thereof. According to the present invention, a structur...  
WO/2023/221868A1
Provided in the present invention are a derivative of an isoxazoline compound and the use thereof in the prevention and treatment of parasitic infections. The derivative of the isoxazoline compound has the following general structural fo...  
WO/2023/196616A1
The present disclosure is directed to the synthesis and application of novel compounds having unique and desired flavor and/or fragrance characteristics. The compounds of the present disclosure can be employed alone or incorporated as fr...  
WO/2023/178266A2
The present disclosure relates to fluorinated phenylamino compounds, their pharmaceutical compositions, and methods for treating one or more tumors or cancers selected from the group consisting of plexiform neurofibromas (PN), plexiform ...  
WO/2023/144798A1
Certain embodiments of the invention provide ionizable lipids having optimized clearance properties. Certain embodiments of the invention also provide nucleic acid-lipid particles comprising ionizable lipids, methods of making the lipid ...  
WO/2023/135341A1
The invention relates to a urease inhibiting composition containing at least one of the compounds of formulas (I), (II) and (III) or a combination thereof: 1,4-dihydroxy-3,6-diisobutylpiperazine-2,5-dione (I), 2-[(N-hydroxyleucyl)-imino]...  
WO/2023/133875A1
Provided is a multifunctional group metal corrosion inhibitor, as shown in one or more of formula (I-a) to formula (I-c). The metal corrosion inhibitor is a multifunctional group metal corrosion inhibitor comprising Schiff base or a deri...  
WO/2023/124970A1
Disclosed are a cyclic 1,3-diketodiimine compound with a symmetrical structure, a synthesis method and use thereof. The compound has a structure represented by the following general formula (III), (II), or (III): wherein R1-R5 are each i...  
WO/2023/125001A1
A cyclic 1,3-diketonediimine compound, and a synthesis method therefor and the use thereof. The cyclic 1,3-diketonediimine compound has a structure as shown in the following general formulas I, II or III, wherein R1-R8 are each independe...  
WO/2023/112722A1
The present invention addresses the problem of providing: a compound suitably used for forming an optical anisotropic membrane that has excellent reverse wavelength dispersion property and moist heat durability; a polymerizable compositi...  
WO/2023/104616A1
The invention relates to a novel method for producing isoxazolinecarboxylic acid derivatives of formula (I).  
WO/2023/101319A1
The present invention relates to a method for preparing an oxime derivative more easily by using a nitrogen oxide as a NO supply source under mild conditions.  
WO/2023/097386A1
The present invention relates to selective HDAC6-inhibiting N-acylhydrazone compounds. More specifically, the present invention relates to N-acylhydrazone compounds of formula (I), and to the methods for producing same, compositions, kit...  
WO/2023/097259A1
The invention discloses novel RAR gamma selective agonists used in the treatment of cancer. The invention also discloses administration of RAR gamma selective agonists to mammals, including humans for the purpose of selectively activatin...  
WO/2023/082149A1
The present disclosure relates to novel intermediates, preparation process thereof, and a process for producing isofetamid. The present disclosure also relates to the use of novel intermediates for preparing isofetamid. The present discl...  
WO/2023/085056A1
An embodiment of the present invention provides: a curable composition comprising a radical polymerization initiator represented by formula 1 and a radically polymerizable compound; a method for producing a cured product of the curable c...  
WO/2023/074527A1
The present invention addresses the problem of providing: a crystalline composition comprising a benzoxazine compound represented by general formula (1); and a method for producing same. As a solution, provided is a crystalline compositi...  
WO/2023/072670A1
The present invention relates to the use of strobilurin type compounds of formula I and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b ...  
WO/2023/060811A1
Disclosed in the present invention are a fluralaner intermediate and a method for preparing fluralaner thereby. The fluralaner intermediate-5 is aaa. A synthetic route comprises: using m-xylene as a starting raw material, performing halo...  
WO/2023/044343A1
The present disclosure details various lipids, compositions, and/or methods of optimized systems and delivery vehicles for the delivery of nucleic acid sequences, polypeptides or peptides for use in vaccinating against infectious agents.  
WO/2023/285883A1
Disclosed herein are embodiments of a bi-functionalized dicyclopentadiene monomer and polymer embodiments formed therefrom. The monomer embodiments exhibit tunability and can be used to form thermally stable homopolymers, copolymers, and...  
WO/2023/280630A1
The present invention relates to a process for the preparation of substituted amidoximes of formula I, which can be obtained through reaction of nitrile compounds of formula II with free hydroxylamine in the presence of a solvent.  
WO/2023/279773A1
Provided are a preparation method for a tedizolid intermediate represented by formula (I), and an intermediate. The method comprises: 1) reacting 2-fluoro-4-substituted phenylacetic acid with a Vilsmeier reagent, and then adding a reacti...  
WO/2023/279205A1
The present technology relates to UV radiation-absorbing and/or visible radiation-absorbing compounds, and use of same in the preparation of compositions for protecting biological and nonbiological material against UV and/or visible radi...  
WO/2023/275221A1
The present invention relates to metal complexes and their use as metal oxide precursors for optical and microelectronic applications. The metal complexes comprise one or more metals M selected from V, Nb and Ta and one or more organic o...  
WO/2022/261956A1
It is described the use of a compound according to formula (I) as precursor in perfumery for generating a ketone or aldehyde of formula (II).  
WO/2022/257957A1
The present invention relates to a use of γ,δ-unsaturated oxime ester compounds of formula (I) as photoinitiators, wherein variables are as defined in the description. The present invention further relates to a preparation method for t...  
WO/2022/249003A1
The present invention relates to an improved process for the preparation of intermediate of Trifloxystrobin in single isolation stage. The present invention provides an improved process for the preparation of (E)-2-(2-halomethylphenyl)-2...  
WO/2022/227923A1
The present invention belongs to the field of organic synthesis, and particularly relates to a hexadecane tromethamine compound. The compound comprises the following structural formula (I). Also provided are a synthesis method therefor a...  
WO/2022/207428A1
A compound (1), (2), (3), (4), (5), (6), (7), or (8); and double bond regioisomers thereof.  
WO/2022/207427A1
A compound of formula (I)(I).  
WO/2022/193368A1
The present invention belongs to the technical field of medicinal chemistry, and disclosed are a trans-amantadine derivative or a salt thereof, and a preparation method therefor, a composition thereof and the use thereof. Provided in the...  
WO/2022/193369A1
The present invention relates to the technical field of pharmaceutical chemistry. Disclosed is a use of a trans amantadine derivative having a structure as represented by formula I or a pharmaceutically acceptable salt thereof in the pre...  
WO/2022/187271A1
Compound formulations include gadusol or gadusporine that can be used as topicals, such as sunscreens or filters that protect human and animal skin against harmful light like UVA, and UVB, cosmetics, and skin care products. In some examp...  
WO/2022/181793A1
The present invention provides: a compound that is represented by formula (1) (in the formula, the combination of X and L represents a combination or the like in which X is a nitrogen atom and L is an oxygen atom or NH, n represents 1 or...  
WO/2022/174628A1
The invention relates to a method for co-producing adipic acid and cyclohexanone oxime from cyclohexane. The method comprises: (1) subjecting cyclohexane and NO x to oxidation nitration to generate adipic acid, nitrocyclohexane, a nitrog...  
WO/2022/163708A1
Provided is a fluorine-containing ether compound represented by the following formula. R1-R2-CH2-R3-CH2-R4 (wherein R1 is a terminal group that includes an oxime group and is represented by formula (2), R2 is a divalent linking...  
WO/2022/158993A1
The present invention relates to a method for the production of d-erythro-sphingosine and analogs thereof, wherein the method comprises a step of condensing a compound of formula (2): Formula (2), or a salt thereof, wherein R1 is hydroge...  
WO/2022/149459A1
A non-linear optical absorption material according to an aspect of the present disclosure contains, as a main component, a compound represented by formula (1). In formula (1), R1 to R27 contain, independently of each other, at least one ...  
WO/2022/149460A1
A light-absorbing material in one embodiment of the present disclosure contains, as a main component, the compound represented by formula 1 below. In formula 1, R1 through R28 contain, independently from one another, at least one atom se...  
WO/2022/138478A1
Provided is a fluorine-containing ether compound represented by the following formula. R1-R2-CH2-R3-CH2-R4-R5 (R1 and R5 each represent a terminal group represented by formula (2) and including an oxime group, R2 and R4 each represent a ...  
WO/2022/126942A1
The present invention relates to the field of synthesis and preparation of medical intermediates. Disclosed is a synthesis method for a medical intermediate cyclopropyl-containing chiral amine hydrochloride. According to the present inve...  
WO/2022/110930A1
The present invention provides a method for ammoximation of macrocycloalkanone, comprising the following steps: adding hydrogen peroxide, ammonia water, a hydroxylamine stabilizer, an oximation catalyst, a solvent, and a macrocycloalkano...  
WO/2022/084254A1
The present invention describes a mixture of isomeric aldimines of the formulae (Ia), (Ib) and (Ic) in which the ratio of the trans,trans isomer (Ia) to the sum of the cis,trans isomer (Ib) and the cis,cis isomer (Ic) is in the range of ...  

Matches 1 - 50 out of 5,404